# Nanjing MilestonePharma Co. Ltd. – FDA Inspection, Aug 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/nanjing-milestonepharma-co-ltd/8ff2797e-5772-4149-8196-732e7ccb171c
Source feed: FDA_Inspections

> FDA inspection 1215544 of Nanjing MilestonePharma Co. Ltd., August 01, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215544
- Company Name: Nanjing MilestonePharma Co. Ltd.
- Inspection Date: 2023-08-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kevin-p-regan/b870e1f2-017c-44ab-bc99-1ca99b474a04)
- [Company Rep](https://www.keypedia.com/people/timothy-h-vo/08da7ca5-7f58-42bf-8046-e3a1bf879b48)

Company: https://www.keypedia.com/companies/nanjing-milestonepharma-co-ltd/48480205-9900-4ed8-83ab-5c6537a445eb

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8